T0	Limitation 24366 24370	This
T1	Limitation 24527 24535	Although
T2	Limitation 24804 24806	In
T3	Limitation 25023 25031	Finally,
T4	Limitation 25373 25381	However,
T5	RelevantOutcomeExcluded 24366 24436	This study did not evaluate atherosclerosis at the carotid bifurcation
T6	RelevantOutcomeExcluded 24485 24525	nor did it quantify plaque lipid content
T7	OutcomeMeasures 24624 24675	they offer no direct measure of plaque inflammation
T8	DiagnosticCriteria 24819 24893	no attempt was made to select subjects on the basis of inflammatory status
T9	Intervention 25071 25169	the dose of canakinumab was not high enough to generate a maximal effect on atherosclerotic burden
T10	SampleSize 25382 25398	this small study
